May 4, 2016:
Over the past three decades, more people have had skin cancer than all other cancers combined. This May, the Big Ten Cancer Research Consortium is bringing awareness to this common – yet highly preventable – form of cancer.
May 4, 2016:
Over the past three decades, more people have had skin cancer than all other cancers combined. This May, the Big Ten Cancer Research Consortium is bringing awareness to this common – yet highly preventable – form of cancer.
April 29, 2016: Al B. Benson III, MD, associate director for cooperative groups at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, was elected president of the National Patient Advocate Foundation’s (NPAF) Executive Board. An esteemed oncologist and professor of medicine in the Division of Hematology/Oncology at the Feinberg School of Medicine, Dr. Benson brings insights into the issues and roadblocks patients face as they navigate the healthcare system to this new role. Read More
Apr. 19, 2016: The fight against cancer is greatly defined by the sheer multitude of challenges involved, the victory over which requires unique capabilities. In this month's edition of Across the Consortium, see shining examples of the unique skills, expertise, knowledge, and passion of each member institution, and be reminded why we are stronger together. Read More
April 5, 2016: While advocating for the creation of Philadelphia’s first firefighting organization, Benjamin Franklin offered his now famous advice: “an ounce of prevention is worth a pound of cure.” That adage continues to resonate with us as the fires of cancer continue ravaging the nation nearly 280 years later posing as the second leading cause of death. In his proclamation for National Cancer Control Month this year, President Obama encouraged citizens, government agencies, businesses, nonprofit organizations, and other groups to join together in efforts to “increase awareness of what Americans can do to prevent and control cancer.” Read on to learn what a few...
April 1, 2016: A conversation with Theodore Lawrence, MD, PhD, director of the University of Michigan Comprehensive Cancer Center, professor and chair of the Department of Radiation Oncology, and a member of the Big Ten Cancer Research Consortium. Q: How do you think cancer research will change in the next 10 to 20 years? There has never been a more exciting time to do cancer research. Over the next 10-20 years, I expect that immunotherapy will continue to advance. We’ll start to see greater clarity in patient selection and in combining immunotherapies with other therapies. Metabolomics is another exciting area of research, and I anticipate that the biological discoveries in this area will begin to be...
April 1, 2016: In this month's Q&A, Big Ten Cancer Research Consortium (Big Ten CRC) Administrative Headquarters addresses common questions related to data processes and capabilities. What electronic data capture system (EDC) does Big Ten CRC Administrative Headquarters use for clinical trials? The Big Ten CRC Administrative Headquarters uses OnCore Enterprise Research Electronic Data Capture Module (EDC), a product of Forte Research Systems. EDC is part of the larger OnCore Enterprise Research System that allows for protocol, subject, and data management in one centralized place. OnCore’s EDC provides the following key features: Read More
March 20, 2016: A game-plan is strategy in motion - the key to a winning plan is insightful strategy. The team-research culture of the Big Ten Cancer Research Consortium fosters such insight, and Big Ten CRC member institutions are positioned to win. In this month’s edition of Across the Consortium, we take note of crucial plays made possible by the members' plan to rapidly drive from ideas to new approaches to cancer treatment. Read More
March 4, 2016: In this month's Q&A, Big Ten Cancer Research Consortium (Big Ten CRC) Administrative Headquarters addresses common questions related to monitoring. Monitoring staff at Big Ten CRC Administrative Headquarters will perform risk-based monitoring as outlined in our Data Monitoring Plans. Site monitoring is an essential part of the Big Ten CRC's ability to successfully run trials. Monitoring staff will source verify critical data elements in the patient charts to what is entered into the OnCore database. Critical data is identified as data supporting the primary and secondary objectives (e.g., eligibility, treatment data, disease evaluations, adverse events, serious adverse events, specified tests, etc.). Read More
March 4, 2016: Among cancers that affect both men and women, colorectal cancer (cancer of the colon or rectum) is the second leading cause of cancer deaths in the United States. The Centers for Disease Control and Prevention (CDC) reports that every year about 140,000 Americans are diagnosed with colorectal cancer, and more than 50,000 people die from it. March is "Colorectal Cancer Awareness Month,” a time to purposefully support patients, rally researchers, and educate all, as we focus on reducing the burden of and working toward a cure for this deadly disease. The member institutions of the Big Ten Cancer Research Consortium continue leading this charge, united in purpose and diverse in talent.
Feb. 18, 2016: Opportunity is knocking Across the Consortium, and member institutions of The Big Ten Cancer Research Consortium are opening doors to greater innovation and impact. Through powerful partnerships, visionary leadership, an "all-in" investment in infrastructure, research, and outreach, members are unlocking answers for today, promise for tomorrow, hope that reaches beyond borders, and decades of vision now realized. Read More
© 2025 All rights reserved.
Big Ten Cancer Research Consortium
7676 Interactive Way, Suite 120, Indianapolis, IN 46278
Subscribe to the Big Ten CRC NewsletterXFacebookYouTube